![]() The plasma level of all coagulation tests revealed statistically significant difference between patient and control group except for PT (p50 years) was associated with higher D-dimer levels (p=0.003). ![]() Twenty-two percent of the group consisted of metastatic breast cancer patients. Median age of diagnosis was 51 years old (range 26-82). Pretreatment blood coagulation tests including PT, APTT, PTA, INR, D-dimer, fibrinogen levels, and platelet counts were evaluated. A total of 123 female breast cancer patients were enrolled into the study. The aim of this study is to explore the correlation of blood coagulation assays for various clinicopathologic factors in breast cancer patients. Tas, Faruk Kilic, Leyla Duranyildiz, DeryaĪctivated coagulation and fibrinolytic system in cancer patients is associated with tumor stroma formation and metastasis in different cancer types. Coagulation tests show significant differences in patients with breast cancer.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |